Serge Belanger
Stock Analyst at Needham
(3.89)
# 618
Out of 4,893 analysts
361
Total ratings
48.39%
Success rate
10%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $17 | $8.88 | +91.44% | 15 | Jun 27, 2025 | |
| CRMD CorMedix | Maintains: Buy | $15 → $20 | $11.71 | +70.79% | 18 | Jun 24, 2025 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Buy | $40 | $22.02 | +81.65% | 9 | Jun 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $25 → $32 | $14.15 | +126.15% | 32 | Jun 2, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $20 | $15.27 | +30.98% | 21 | May 23, 2025 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $36 | $17.12 | +110.34% | 17 | May 20, 2025 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $24 | $6.41 | +274.41% | 21 | May 20, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $3.46 | - | 7 | May 16, 2025 | |
| CLSD Clearside Biomedical | Maintains: Buy | $4 → $3 | $0.88 | +242.66% | 15 | May 15, 2025 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Hold | n/a | $0.87 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $36.59 | +96.78% | 23 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $66 | $48.88 | +35.02% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $32.98 | +66.77% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $23.71 | +26.53% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $9.73 | +126.10% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.24 | +222.58% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $11.08 | +26.35% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.22 | +80.18% | 22 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $22.21 | - | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $33.03 | +39.27% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $15.51 | +80.53% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.98 | - | 1 | Mar 31, 2022 |
BioCryst Pharmaceuticals
Jun 27, 2025
Reiterates: Buy
Price Target: $17
Current: $8.88
Upside: +91.44%
CorMedix
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.71
Upside: +70.79%
NewAmsterdam Pharma Company
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $22.02
Upside: +81.65%
Liquidia
Jun 2, 2025
Maintains: Buy
Price Target: $25 → $32
Current: $14.15
Upside: +126.15%
Arcutis Biotherapeutics
May 23, 2025
Reiterates: Buy
Price Target: $20
Current: $15.27
Upside: +30.98%
Viridian Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $36
Current: $17.12
Upside: +110.34%
Trevi Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $24
Current: $6.41
Upside: +274.41%
Omeros
May 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.46
Upside: -
Clearside Biomedical
May 15, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.88
Upside: +242.66%
Verrica Pharmaceuticals
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.87
Upside: -
May 14, 2025
Reiterates: Buy
Price Target: $72
Current: $36.59
Upside: +96.78%
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $48.88
Upside: +35.02%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $32.98
Upside: +66.77%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $23.71
Upside: +26.53%
May 8, 2025
Reiterates: Buy
Price Target: $22
Current: $9.73
Upside: +126.10%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.24
Upside: +222.58%
May 6, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $11.08
Upside: +26.35%
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $2.22
Upside: +80.18%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $22.21
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $33.03
Upside: +39.27%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $15.51
Upside: +80.53%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.98
Upside: -